Obsidian Therapeutics

Obsidian is a biotechnology company that is pioneering a new generation of controllable cell and gene therapies for the treatment of diseases such as cancer, utilizing its proprietary cell DRIVE™ technology. According to research from Stanford University, Obsidian's cell DRiVE™ technology provides a method to control cell and gene therapies using proteins provided by FDA-approved small molecules. Headquartered in Cambridge, Massachusetts, Obsidian has assembled a team of industry-leading experts in immunology, cell therapy, and oncology.